Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study

References

• The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):934–947.
   PubMed Web of Science ®Google Scholar
• McGuigan A, Kelly P, Turkington RC, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–4861.
   PubMed Web of Science ®Google Scholar
• Carrato A, Falcone A, Ducreux M, et al. A systematic review of the burden of pancreatic cancer in europe: real-world impact on survival, quality of life and costs. J Gastrointest Cancer. 2015;46(3):201–211.
   PubMedGoogle Scholar
• Petersen GM. Familial pancreatic adenocarcinoma. Hematol Oncol Clin North Am. 2015;29(4):641–653.
   PubMed Web of Science ®Google Scholar
• Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer. 2009;8(2):109–117.
   PubMed Web of Science ®Google Scholar
• Hruban RH, Petersen GM, Ha PK, et al. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am. 1998;7(1):1–23.
   PubMedGoogle Scholar
• Brune KA, Lau B, Palmisano E, et al. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst. 2010;102(2):119–126.
   PubMedGoogle Scholar
• Weble TC, Bjerregaard JK, Kissmeyer P, et al. Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012. Acta Oncol. 2017;56(12):1763–1768.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85.
   PubMed Web of Science ®Google Scholar
• Mucci LA, Hjelmborg JB, Harris JR, et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA. 2016;315(1):68–76.
   PubMed Web of Science ®Google Scholar
• Chen F, Childs EJ, Mocci E, et al. Analysis of heritability and genetic architecture of pancreatic cancer: a PanC4 study. Cancer Epidemiol Biomarkers Prev. 2019;28(7):1238–1245.
   PubMed Web of Science ®Google Scholar
• Tenesa A, Haley CS. The heritability of human disease: estimation, uses and abuses. Nat Rev Genet. 2013;14(2):139–149.
   PubMed Web of Science ®Google Scholar
• Jorgensen MT, Mortensen MB, Gerdes AM, et al. Familial pancreatic cancer. Scand J Gastroenterol. 2008;43(4):387–397.
   PubMed Web of Science ®Google Scholar
• Joergensen MT, Gerdes AM, Sorensen J, et al. Is screening for pancreatic cancer in high-risk groups cost-effective? – experience from a Danish national screening program. Pancreatology. 2016;16(4):584–592.
   PubMed Web of Science ®Google Scholar
• Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7–17.
   PubMed Web of Science ®Google Scholar
• Mohammadi L, Vreeswijk MP, Oldenburg R, et al. A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example. BMC Cancer. 2009;9:211.
   PubMed Web of Science ®Google Scholar
• Moineddin R, Matheson FI, Glazier RH. A simulation study of sample size for multilevel logistic regression models. BMC Med Res Methodol. 2007;7:34.
   PubMed Web of Science ®Google Scholar
• Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. Contemp Clin Trials. 2012;33(5):869–880.
   PubMed Web of Science ®Google Scholar
• Schenk M, Schwartz AG, O'Neal E, et al. Familial risk of pancreatic cancer. J Natl Cancer Inst. 2001;93(8):640–644.
   PubMedGoogle Scholar
• Bartsch DK, Matthäi E, Mintziras I, et al. Characteristics of pure familial pancreatic cancer families and those with additional breast cancer. OAJOM. 2020;4(1):339–346.
   Google Scholar
• Benzel J, Fendrich V. Familial pancreatic cancer. Oncol Res Treat. 2018;41(10):611–618.
   PubMed Web of Science ®Google Scholar
• Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007;56(10):1460–1469.
   PubMed Web of Science ®Google Scholar
• Benzel J, Fendrich V. Chemoprevention and treatment of pancreatic cancer: update and review of the literature. Digestion. 2018;97(4):275–287.
   PubMed Web of Science ®Google Scholar
• Olson SH, Kurtz RC. Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol. 2013;107(1):1–7.
   PubMed Web of Science ®Google Scholar
• Rustgi AK. Familial pancreatic cancer: genetic advances. Genes Dev. 2014;28(1):1–7.
   PubMed Web of Science ®Google Scholar
• Humphris JL, Johns AL, Simpson SH, et al. Clinical and pathologic features of familial pancreatic cancer. Cancer. 2014;120(23):3669–3675.
   PubMed Web of Science ®Google Scholar
• Tan M, Schaffalitzky de Muckadell OB, Joergensen MT. Gene expression network analysis of precursor lesions in familial pancreatic cancer. J Pancreat Cancer. 2020;6(1):73–84.
   PubMed Web of Science ®Google Scholar
• Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol. 2010;7(3):131–145.
   PubMed Web of Science ®Google Scholar
• Steele CW, Jamieson NB, Evans TRJ, et al. Exploiting inflammation for therapeutic gain in pancreatic cancer. Br J Cancer. 2013;108(5):997–1003.
   PubMed Web of Science ®Google Scholar
• Shirts BH, Burt RW, Mulvihill SJ, et al. A population-based description of familial clustering of pancreatic cancer. Clinical gastroenterology and hepatology: the official clinical practice journal of the. Am Gastroenterol Assoc. 2010;8(9):812–816.
   Web of Science ®Google Scholar
• Kohli DR, Smith KR, Wong J, et al. Familial pancreatic cancer risk: a population-based study in Utah. J Gastroenterol. 2019;54(12):1106–1112.
   PubMed Web of Science ®Google Scholar
• Childs EJ, Chaffee KG, Gallinger S, et al. Association of common susceptibility variants of pancreatic cancer in higher-risk patients: A PACGENE study. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1185–1191.
   PubMed Web of Science ®Google Scholar
• Zuk O, Schaffner SF, Samocha K, et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A. 2014;111(4):E455–64.
   PubMed Web of Science ®Google Scholar
• Roberts NJ, Norris AL, Petersen GM, et al. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov. 2016;6(2):166–175.
   PubMed Web of Science ®Google Scholar
• Zhen DB, Rabe KG, Gallinger S, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med. 2015;17(7):569–577.
   PubMed Web of Science ®Google Scholar
• Chaffee KG, Oberg AL, McWilliams RR, et al. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med. 2018;20(1):119–127.
   PubMed Web of Science ®Google Scholar
• Petersen GM. Familial pancreatic cancer. Semin Oncol. 2016;43(5):548–553.
   PubMed Web of Science ®Google Scholar
• Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–1261.
   PubMed Web of Science ®Google Scholar